Philip Morris International experts recently presented scientific evidence to the FDA in support of Modified Risk Tobacco ...

The cigarette and Zyn nicotine pouch maker reports softer-than-expected revenue.

By Angela Christy M and Emma Rumney BENGALURU/LONDON, Feb 6 (Reuters) - Philip Morris International forecast ...

Feb 6 (Reuters) - Philip Morris International forecast higher-than-expected annual profit on Friday, betting on strong sales ...

PMI forecasts 2026 organic net revenue growth of 5% to 7% and organic operating income growth of 7% to 9%. Currency-neutral adjusted diluted EPS growth is projected at 7.5% to 9.5%, translating to ...

Philip Morris seeks FDA MRTP status for ZYN nicotine pouches; learn what it could mean for reduced-risk claims, smoke-free growth, and PM outlook.

Philip Morris International logged higher profit and revenue in the fourth quarter, while forecasting continued growth for years to come.

PM reports fourth quarter earnings growth as pricing strength and smoke-free expansion drove performance despite a revenue ...

Flavored nicotine pouches could soon be advertised as a lower-risk option for adults who smoke, as federal regulators take a closer look at the product.

PMI scientists presented data to the FDA’s Tobacco Products Scientific Advisory Committee (TPSAC) as part of the FDA’s process for a Modified Risk Tobacco Product (MRTP) designation for the company’s ...

Swedish Match’s office in James Center is its U.S. division headquarters and the closure will result in the elimination of ...

The governor’s budget plan would extend the state’s 75% tax on cigarettes to alternative nicotine products like the popular ...